These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4299217)

  • 1. Biochemical aspects of the hyperglycemic action of diazoxide.
    Senft G
    Ann N Y Acad Sci; 1968 Apr; 150(2):242-55. PubMed ID: 4299217
    [No Abstract]   [Full Text] [Related]  

  • 2. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
    Loubatières A; Mariani MM; Alric R
    Ann N Y Acad Sci; 1968 Apr; 150(2):226-41. PubMed ID: 4875709
    [No Abstract]   [Full Text] [Related]  

  • 3. Mode of action of a diazoxide analog (A025). Its effects on insulin secretion.
    Grant AM; Basabe JC; Lopez NL; Krees SV; Wolff FW
    Diabetes; 1970 Sep; 19(9):630-8. PubMed ID: 4990295
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of diazoxide hyperglycemia in animals.
    Tabachnick II; Gulbenkian A
    Ann N Y Acad Sci; 1968 Apr; 150(2):204-18. PubMed ID: 4299216
    [No Abstract]   [Full Text] [Related]  

  • 5. Diazoxide-induced long-term hyperglycemia. I. Preservation of B-cell insulin-releasing capacity.
    Gomis R; Plaza C; Malaisse WJ
    Diabetes Res; 1988 Dec; 9(4):183-6. PubMed ID: 3073904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.
    Fajans SS; Floyd JC; Thiffault CA; Knopf RF; Harrison TS; Conn JW
    Ann N Y Acad Sci; 1968 Apr; 150(2):261-80. PubMed ID: 4299219
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of diazoxide and benzothiadiazine diuretics upon phosphodiesterase.
    Moore PF
    Ann N Y Acad Sci; 1968 Apr; 150(2):256-60. PubMed ID: 4299218
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system.
    Porte D; Robertson RP
    Fed Proc; 1973 Jul; 32(7):1792-6. PubMed ID: 4352448
    [No Abstract]   [Full Text] [Related]  

  • 9. [Insulin secretion in vitro. II. Inhibition of glucose induced insulin release by diazoxide].
    Frerichs H; Gerber R; Creutzfeldt W
    Diabetologia; 1966 Dec; 2(4):269-76. PubMed ID: 4902707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibition of insulin secretion by alpha adrenergic stimulatory agents].
    Senft G; Sitt R; Losert W; Schultz G; Hoffmann M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(4):309-23. PubMed ID: 4300750
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies concerning the hyperglycemic effects of diazoxide and its mode of action.
    Yabo R; Viktora J; Staquet M; Wolff F
    Diabetes; 1965 Sep; 14(9):591-4. PubMed ID: 5318830
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of imidazole upon insulin secretion.
    Malaisse WJ; Malaisse-Lagae F
    Diabetes; 1968; 17():308. PubMed ID: 4297287
    [No Abstract]   [Full Text] [Related]  

  • 13. Diazoxide unmasks glucose inhibition of insulin release by counteracting entry of Ca2+.
    Bergsten P; Gylfe E; Wesslén N; Hellman B
    Am J Physiol; 1988 Oct; 255(4 Pt 1):E422-7. PubMed ID: 3052102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diazoxide.
    Br Med J; 1972 Nov; 4(5837):417-8. PubMed ID: 4344353
    [No Abstract]   [Full Text] [Related]  

  • 15. Diazoxide and the secretion of insulin.
    Nutr Rev; 1972 Aug; 30(8):194-8. PubMed ID: 4340200
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.
    Seltzer HS; Crout JR
    Ann N Y Acad Sci; 1968 Apr; 150(2):309-21. PubMed ID: 4875710
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
    Loubatiéres A; Mariani MM
    Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of adenosine 3':5'-cyclic monophosphate in the regulation of insulin release by isolated rat islets of Langerhans.
    Montague W; Cook JR
    Biochem J; 1971 Mar; 122(1):115-20. PubMed ID: 4330960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats.
    Leahy JL; Bumbalo LM; Chen C
    Diabetes; 1994 Feb; 43(2):173-9. PubMed ID: 8288040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AO44: an improved hyperglycemic agent.
    Lopez N; Basabe J; Grant A; Krees S; Terry M; Viktora J; Wolff F
    Metabolism; 1971 Apr; 20(4):373-83. PubMed ID: 5550304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.